IRF9 anticorps
-
- Antigène Voir toutes IRF9 Anticorps
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp IRF9 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP)
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- interferon regulatory factor 9
- Isotype
- IgG
- Top Product
- Discover our top product IRF9 Anticorps primaire
-
anti-Interferon Regulatory Factor 9 (IRF9) (AA 75-104) antibody
IRF9 Reactivité: Humain, Souris WB, ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 75-104) antibodyIRF9 Reactivité: Humain, Souris WB, IF, IHC (p) Hôte: Lapin Polyclonal RB19229 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 Reactivité: Humain WB, ELISA, IHC (p) Hôte: Souris Monoclonal 1C10 unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) antibodyIRF9 Reactivité: Humain IF, FACS Hôte: Souris Monoclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 101-200) antibodyIRF9 Reactivité: Humain WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro), ICC Hôte: Lapin Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) antibodyIRF9 Reactivité: Humain, Souris WB, ELISA, IHC Hôte: Lapin Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 Reactivité: Humain WB, IP Hôte: Lapin Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 171-393) antibodyIRF9 Reactivité: Humain WB, IHC, IF, IHC (p), ICC Hôte: Lapin Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 44-180) antibodyIRF9 Reactivité: Humain WB, ELISA, IF Hôte: Lapin Polyclonal unconjugated
anti-Interferon Regulatory Factor 9 (IRF9) (AA 1-393) antibodyIRF9 Reactivité: Humain WB, IF Hôte: Souris Polyclonal unconjugated
-
- Indications d'application
- WB: 1:500-1:1000, IP: 1:500-1:1000, IHC: 1:50-1:500, IF: 1:20-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
- Autre désignation
- IRF9 (IRF9 Produits)
- Synonymes
- anticorps IRF-9, anticorps ISGF3, anticorps ISGF3G, anticorps p48, anticorps zgc:92097, anticorps Irf-9, anticorps Isgf3g, anticorps interferon regulatory factor 9, anticorps IRF9, anticorps irf9, anticorps Irf9
- Sujet
- Synonyms:interferon regulatory factor 9, IRF 9, IRF9, ISGF 3 gamma, ISGF3, ISGF3 p48 subunit, ISGF3G, p48 Background:Transcription factor that mediates signaling by type I IFNs(IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases(TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. IRF9/ISGF3G associates with the phosphorylated STAT1:STAT2 dimer to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element(ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.
- Poids moléculaire
- 48kd
- ID gène
- 10379
- UniProt
- Q00978
- Pathways
- Signalistation JAK/STAT, Interferon-gamma Pathway, Hepatitis C
-
